The Inhibitory Effect of ErbB2 on Epidermal Growth Factor-induced Formation of Clathrin-coated Pits Correlates with Retention of Epidermal Growth Factor Receptor-ErbB2 Oligomeric Complexes at the Plasma Membrane

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2005 Oct 7

PMID 16207817

Citations 42

Authors

Camilla Haslekas

Kamilla Breen

Ketil W Pedersen

Lene E Johannessen

Espen Stang

Inger Helene Madshus

Affiliations

Soon will be listed here.

Abstract

By constructing stably transfected cells harboring the same amount of epidermal growth factor (EGF) receptor (EGFR), but with increasing overexpression of ErbB2, we have demonstrated that ErbB2 efficiently inhibits internalization of ligand-bound EGFR. Apparently, ErbB2 inhibits internalization of EGF-bound EGFR by constitutively driving EGFR-ErbB2 hetero/oligomerization. We have demonstrated that ErbB2 does not inhibit phosphorylation or ubiquitination of the EGFR. Our data further indicate that the endocytosis deficiency of ErbB2 and of EGFR-ErbB2 heterodimers/oligomers cannot be explained by anchoring of ErbB2 to PDZ-containing proteins such as Erbin. Instead, we demonstrate that in contrast to EGFR homodimers, which are capable of inducing new clathrin-coated pits in serum-starved cells upon incubation with EGF, clathrin-coated pits are not induced upon activation of EGFR-ErbB2 heterodimers/oligomers.

Citing Articles

A trafficking regulatory subnetwork governs αβ integrin-HER2 cross-talk to control breast cancer invasion and drug resistance.

Maldonado H, Dreger M, Bedgood L, Kyriakou T, Wolanska K, Rigby M Sci Adv. 2024; 10(49):eadk9944.

PMID: 39630893 PMC: 11616693. DOI: 10.1126/sciadv.adk9944.

EGFR trafficking: effect of dimerization, dynamics, and mutation.

Schultz D, Billadeau D, Jois S Front Oncol. 2023; 13:1258371.

PMID: 37752992 PMC: 10518470. DOI: 10.3389/fonc.2023.1258371.

Structure and dynamics of the EGFR/HER2 heterodimer.

Bai X, Sun P, Wang X, Long C, Liao S, Dang S Cell Discov. 2023; 9(1):18.

PMID: 36781849 PMC: 9925823. DOI: 10.1038/s41421-023-00523-5.

Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)-A Necessity for Future ADC Research and Development.

Hammood M, Craig A, Leyton J Pharmaceuticals (Basel). 2021; 14(7).

PMID: 34358100 PMC: 8308841. DOI: 10.3390/ph14070674.

Mechanism of p38 MAPK-induced EGFR endocytosis and its crosstalk with ligand-induced pathways.

Perez Verdaguer M, Zhang T, Paulo J, Gygi S, Watkins S, Sakurai H J Cell Biol. 2021; 220(7).

PMID: 34032851 PMC: 8155814. DOI: 10.1083/jcb.202102005.

References

Griffiths G, Simons K, Warren G, Tokuyasu K . Immunoelectron microscopy using thin, frozen sections: application to studies of the intracellular transport of Semliki Forest virus spike glycoproteins. Methods Enzymol. 1983; 96:466-85. DOI: 10.1016/s0076-6879(83)96041-x. View

Spencer K, Leng J, Hynes N, Klemke R . ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J Cell Biol. 2000; 148(2):385-97. PMC: 2174273. DOI: 10.1083/jcb.148.2.385. View

Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View

Di Fiore P, PIERCE J, Kraus M, Segatto O, King C, Aaronson S . erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 1987; 237(4811):178-82. DOI: 10.1126/science.2885917. View

Lund K, Opresko L, Starbuck C, Walsh B, Wiley H . Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J Biol Chem. 1990; 265(26):15713-23. View

Chazin V, Kaleko M, Miller A, Slamon D . Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor. Oncogene. 1992; 7(9):1859-66. View

Sorkin A, Di Fiore P, Carpenter G . The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Oncogene. 1993; 8(11):3021-8. View

Sliwkowski M, Schaefer G, Akita R, Lofgren J, FITZPATRICK V, Nuijens A . Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem. 1994; 269(20):14661-5. View

Wallasch C, Weiss F, Niederfellner G, Jallal B, Issing W, Ullrich A . Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 1995; 14(17):4267-75. PMC: 394510. DOI: 10.1002/j.1460-2075.1995.tb00101.x. View

10.

Baulida J, Kraus M, Alimandi M, Di Fiore P, Carpenter G . All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem. 1996; 271(9):5251-7. DOI: 10.1074/jbc.271.9.5251. View

11.

Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L . Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 1996; 15(10):2452-67. PMC: 450177. View

12.

Lenferink A, Pinkas-Kramarski R, van de Poll M, van Vugt M, Klapper L, Tzahar E . Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J. 1998; 17(12):3385-97. PMC: 1170676. DOI: 10.1093/emboj/17.12.3385. View

13.

Garrett T, McKern N, Lou M, Elleman T, Adams T, Lovrecz G . Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell. 2002; 110(6):763-73. DOI: 10.1016/s0092-8674(02)00940-6. View

14.

Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim J . Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 2002; 110(6):775-87. DOI: 10.1016/s0092-8674(02)00963-7. View

15.

Birrane G, Chung J, Ladias J . Novel mode of ligand recognition by the Erbin PDZ domain. J Biol Chem. 2002; 278(3):1399-402. DOI: 10.1074/jbc.C200571200. View

16.

Garrett T, McKern N, Lou M, Elleman T, Adams T, Lovrecz G . The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol Cell. 2003; 11(2):495-505. DOI: 10.1016/s1097-2765(03)00048-0. View

17.

Jiang X, Huang F, Marusyk A, Sorkin A . Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell. 2003; 14(3):858-70. PMC: 151565. DOI: 10.1091/mbc.e02-08-0532. View

18.

Shelly M, Mosesson Y, Citri A, Lavi S, Zwang Y, Melamed-Book N . Polar expression of ErbB-2/HER2 in epithelia. Bimodal regulation by Lin-7. Dev Cell. 2003; 5(3):475-86. DOI: 10.1016/j.devcel.2003.08.001. View

19.

Hendriks B, Wiley H, Lauffenburger D . HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms. Biophys J. 2003; 85(4):2732-45. PMC: 1303497. DOI: 10.1016/S0006-3495(03)74696-7. View

20.

Hommelgaard A, Lerdrup M, van Deurs B . Association with membrane protrusions makes ErbB2 an internalization-resistant receptor. Mol Biol Cell. 2004; 15(4):1557-67. PMC: 379255. DOI: 10.1091/mbc.e03-08-0596. View